Use of inflammatory markers for early detection of bacteraemia in patients with febrile neutropenia

被引:73
作者
Persson, L [1 ]
Engervall, P
Magnuson, A
Vikerfors, T
Söderquist, B
Hansson, LO
Tidefelt, U
机构
[1] Orebro Univ Hosp, Dept Infect Dis, SE-70185 Orebro, Sweden
[2] Orebro Univ Hosp, Dept Internal Med, SE-70185 Orebro, Sweden
[3] Orebro Univ Hosp, Clin Res Ctr, Stat Unit, SE-70185 Orebro, Sweden
[4] Univ Orebro, Dept Clin Med, SE-70185 Orebro, Sweden
[5] Karolinska Hosp, Karolinska Lab, Dept Haematol, S-10401 Stockholm, Sweden
[6] Karolinska Hosp, Karolinska Lab, Dept Clin Chem, S-10401 Stockholm, Sweden
[7] Karolinska Inst, Stockholm, Sweden
关键词
D O I
10.1080/00365540410020217
中图分类号
R51 [传染病];
学科分类号
100401 [流行病与卫生统计学];
摘要
The aim of the study was to evaluate the ability of procalcitonin, C-reactive protein, serum amyloid A, interleukin-6 and interleukin-8 to predict bacteraemia during the 2 first d of fever in neutropenic patients. A total of 94 febrile neutropenic episodes in 60 patients were studied. Plasma samples were analysed at 10-h intervals from the onset of fever. Clinical events were categorized into 4 groups: 1) bacteraemia caused by other agents than coagulase-negative staphylococci (non-CNS bacteraemia) (n = 21), 2) coagulase-negative staphylococci bacteraemia (n = 15), 3) microbiologically or clinically documented infection without bacteraemia (n = 26) and 4) fever of unknown origin (n = 32). In non-CNS bacteraemia all markers, except for serum amyloid A, showed significantly higher levels compared to patients with fever of unknown origin (p < 0.05). For non-CNS bacteraemia the highest negative predictive value was found for procalcitonin (94%), followed by interleukin-6 (89%), C-reactive protein (88%) and interleukin-8 (87%). Procalcitonin, with a cut-off level of 1.4 ng/ml during 10-20 h after fever onset, showed the highest positive predictive value (67%) for a non-CNS bacteraemia. In conclusion, the value of the analysed markers to predict a non-CNS bacteraemia in neutropenic patients was limited due to low sensitivity and positive predictive value. However, procalcitonin, interleukin-6, C-reactive protein, and interleukin-8 could give useful information for the clinician in excluding a non-CNS bacteraemia.
引用
收藏
页码:365 / 371
页数:7
相关论文
共 30 条
[1]
HIGH IL-6 SERUM LEVELS ARE ASSOCIATED WITH SEPTIC SHOCK AND MORTALITY IN SEPTIC PATIENTS WITH SEVERE LEUKOPENIA DUE TO HEMATOLOGICAL MALIGNANCIES [J].
ANTONELLI, M ;
RAPONI, GM ;
MARTINO, P ;
ROSA, G ;
CONTI, G ;
JALOUK, J ;
GASPARETTO, A .
SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 1995, 27 (04) :381-384
[2]
Arber C, 2000, SCAND J INFECT DIS, V32, P515, DOI 10.1080/003655400458802
[3]
HIGH SERUM PROCALCITONIN CONCENTRATIONS IN PATIENTS WITH SEPSIS AND INFECTION [J].
ASSICOT, M ;
GENDREL, D ;
CARSIN, H ;
RAYMOND, J ;
GUILBAUD, J ;
BOHUON, C .
LANCET, 1993, 341 (8844) :515-518
[4]
Procalcitonin as an early marker of bacterial infection in severely neutropenic febrile adults [J].
Bernard, L ;
Ferrière, F ;
Casassus, P ;
Malas, F ;
Lévêque, S ;
Guillevin, L ;
Lortholary, O .
CLINICAL INFECTIOUS DISEASES, 1998, 27 (04) :914-915
[5]
Kinetics of procalcitonin in iatrogenic sepsis [J].
Brunkhorst, FM ;
Heinz, U ;
Forycki, ZF .
INTENSIVE CARE MEDICINE, 1998, 24 (08) :888-889
[6]
PROCALCITONIN INCREASE AFTER ENDOTOXIN INJECTION IN NORMAL SUBJECTS [J].
DANDONA, P ;
NIX, D ;
WILSON, MF ;
ALJADA, A ;
LOVE, J ;
ASSICOT, M ;
BOHUON, C .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1994, 79 (06) :1605-1608
[7]
Plasma IL-8 and IL-6 levels can be used to define a group with low risk of septicaemia among cancer patients with fever and neutropenia [J].
de Bont, ESJM ;
Vellenga, E ;
Swaanenburg, JCJM ;
Fidler, V ;
Visser-van Brummen, PJ ;
Kamps, WA .
BRITISH JOURNAL OF HAEMATOLOGY, 1999, 107 (02) :375-380
[8]
Engel A, 1999, SCAND J INFECT DIS, V31, P185, DOI 10.1080/003655499750006254
[9]
ENGERVALL P, 1995, EUR J HAEMATOL, V54, P226
[10]
CLINICAL-SIGNIFICANCE OF SERUM CYTOKINE PATTERNS DURING START OF FEVER IN PATIENTS WITH NEUTROPENIA [J].
ENGERVALL, P ;
ANDERSSON, B ;
BJORKHOLM, M .
BRITISH JOURNAL OF HAEMATOLOGY, 1995, 91 (04) :838-845